Importance of Physicochemical Characterization Prior to Immunological Studies

Handbook of Immunological Properties of Engineered Nanomaterials: Second Edition

Volumn 1, Issue , 2016, Pages 25-52

  Clogston, Jeffrey D ^a   Patri, Anil K ^b  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHARACTERIZATION; CHEMICAL STABILITY; LIGHT SCATTERING; NANOPARTICLES;

IMMUNOLOGICAL PROPERTIES; ON DYNAMICS; PHYSICAL AND CHEMICAL PROPERTIES; PHYSICO-CHEMICAL CHARACTERIZATION; ZETA POTENTIAL MEASUREMENTS;

PARAMETER ESTIMATION;

EID: 85017538042     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9677     Document Type: Chapter

References (27)

1. McNeil SE. Nanotechnology for the biologist. J Leukoc Biol 2005;78:585-594.
2. McNeil SE. Nanoparticle therapeutics: A personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;1:264-271.
3. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects. Bioconjug Chem 2010;21:797-802.
4. Adiseshaiah P, Hall JB, McNeil SE. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;2:99-112.
5. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 2009;5:106-117.
6. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo. J Controlled Release 2000;65:133-148.
7. Scholer N, Hahn H, Muller RH, Liesenfeld O. Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm 2002;231:167-176.
8. Kobayashi H, Brechbiel MW. Dendrimer-based macromolecular MRI contrast agents: Characteristics and application. Mol Imaging 2003;2:1-10.
9. Kobayashi H, Kawamoto S, Jo SK, Bryant HL Jr, Brechbiel MW, Star RA. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores. Bioconjug Chem 2003:14;388-394.
10. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007;2:469-478.
11. Salvador-Morales C, Zhang L, Langer R, Farokhzad OC. Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials 2009;30:2231-2240.
12. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Delivery Rev 2009;61:428-437.
13. Patri AK, Dobrovolskaia MA, Stern ST, McNeil SE. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics. In: Amiji M (ed.), Nanotechnology for Cancer Therapy. CRC Press, 2007, pp. 104-113.
14. Dong MW. Modern HPLC for Practicing Scientists. John Wiley & Sons, 2006, pp. 1-14.
15. Islam MT, Shi X, Balogh L, Baker JR, Jr. HPLC Separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups. Anal Chem 2005; 77:2063-2070.
16. Singh R, Ajagbe M, Bhamidipati S, Ahmad Z, Ahmad I. A rapid isocratic high-performance liquid chromatography method for determination of cholesterol and 1,2-dioleoylsn-glycero-3-phosphocholine in liposome-based drug formulations. J Chromatogr A 2005; 1073:347-353.
17. Wei G, Xiao S, Si D, Liu C. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations. Biomed Chromatogr 2008;22:1252-1258.
18. Vernooij EA, Kettenes-van den Bosch JJ, Underberg WJ, Crommelin DJ. Chemical hydrolysis of DOTAP and DOPE in a liposomal environment. J Controlled Release 2002; 79:299-303.
19. Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR, Jr. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality. Biomacromolecules 2006;7:72-579.
20. Arifin DR, Palmer AF. Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering. Biotechnol Prog 2003; 19:1798-1811.
21. Cho TJ, Hackley VA. Fractionation and characterization of gold nanoparticles in aqueous solution: Asymmetric-flow field flow fractionation with MALS, DLS, and UV-Vis detection. Anal Bioanal Chem 2010;398:2003-2018.
22. Chan KC, Patri AK, Veenstra TD, McNeil SE, Issaq HJ. Analysis of fullerene-based nanomaterial in serum matrix by CE. Electrophoresis 2007;28:1518-1524.
23. Brothers HM, II, Piehler LT, Tomalia DA. Slab-gel and capillary electrophoretic characterization of polyamidoamine dendrimers. J Chromatogr A 1998;814:233-246.
24. Hackley VA, Clogston JD. Measuring the hydrodynamic size of nanoparticles in aqueous media using batch-mode dynamic light scattering. In: McNeil SE (ed.), Methods in Molecular Biology, Vol. 697. Characterization of Nanoparticles Intended for Drug Delivery, Humana Press, 2011, pp. 35-52.
25. Berne BJ, Pecora, R. Dynamic Light Scattering with Applications to Chemistry, Biology, and Physics. Dover Publications, 2000, pp. 10-37.
26. Hackley VA, Clogston JD. NIST-NCL Joint Assay Protocol PCC-1, Measuring the size of nanoparticles in aqueous media using batch-mode dynamic light scattering. Retrieved June 1, 2012, from http://ncl.cancer.gov/working_assay-cascade.asp.
27. Malvern Instruments, Zeta potential measurement using laser Doppler electrophoresis (LDE), Retrieved June 1, 2012, from http://www.malvern.com/LabEng/technology/ zeta_potential/zeta_potential_LDE.htm.